Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen

PURPOSE: The extension of endocrine therapy beyond 5 years for recurrence-free survivors of breast cancer improves survival; however, the issue on how to clinically identify appropriate candidates remains controversial. This study aimed to identify prognostic factors for breast-cancer-specific morta...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Soo Yeon, Kwon, Ji Yeong, Lee, Young Joo, Gwark, Sung-chan, Lee, Sae Byul, Kim, Jisun, Chung, Il Yong, Ko, Beom Seok, Kim, Hee Jeong, Kim, Sung-Bae, Ahn, Seung Do, Gong, Gyungyub, Son, Byung Ho, Ahn, Sei-Hyun, Lee, Jong Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769394/
https://www.ncbi.nlm.nih.gov/pubmed/31598339
http://dx.doi.org/10.4048/jbc.2019.22.e33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769394/
https://www.ncbi.nlm.nih.gov/pubmed/31598339
http://dx.doi.org/10.4048/jbc.2019.22.e33

Ejemplares similares